Summary
The thalidomide tragedy gave rise to national drug regulation without thought to international harmonization. Thus from the early days of the European Community (EC), there has been a barrier to the free movement of medicinal products. Previous attempts have failed to resolve the problem and the European Commission is currently involved in attempting to establish Community drug legislation which will remove these barriers and create a single internal market.
The Commission advocates two procedures (a centralized and a decentralized) largely under the control of the Committee for Proprietary Medicinal Products (CPMP) within the framework of a new European Agency for the Evaluation of Medicinal Products. The present authority of the Commission to make decisions binding on all 12 Member States will be utilized by the CPMP.
While the present draft legislation should create significant improvement towards the goal of a single market, it contains some areas of potential concern. That this major venture should be a success is not only critical to the EC economy, its research-based pharmaceutical industry and the health care of its citizens but also to the achievement of global harmonization for pharmaceutical marketing authorization for which there is much evidence of enthusiasm and desire.
Similar content being viewed by others
References
Council Directive (1965) (65/65/EEC) Official Journal of the European Communities. 369/65
Council Directive (1983) (83/570/EEC) Article 3. Official Journal of the European Communities, No L332/7
Second Council Directive (1975) (75/319/EEC) Article 8. Official Journal of the European Communities, No L147/15
Currie WJC (1989) The Regulation of Medicines post 1992. Eur J Clin Pharmacol 37: 433–435
Commission of the European Communities (1988) Report From the Commission on the Activities of the Committee for Proprietary Medicinal Products. COM 88: 143
Anon (1990) Preliminary Draft Directives for EEC Future Systems. Scrip 1492: 4–5
Anon (1990) EEC Medicines Agency Described. Scrip 1494: 6–7
Currie WJC (1989) 1992. Is There the Will for There to be a Way? J Clin Pharmacol 29: 770–774
Anon (1990) 1st International Harmonisation Meeting. Scrip 1504: 1
The Scheme for the Mutual Recognition of Evaluation Reports on Pharmaceutical Products (1979) (Revised 1986) Published by the Secretariat of the European Free Trade Association
Anon (1990) Hungarians to seek EEC membership. The Daily Telegraph, published UK, Wednesday May 23, 1990: 10
Anon (1990) Ethics function central in Soviet system. Scrip 1494: 2–3
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Currie, W.J.C. The evolving horizon of drug registration — Europe and beyond. Eur J Clin Pharmacol 39, 453–456 (1990). https://doi.org/10.1007/BF00280935
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280935